Chen et al. found that siRNA-HIF-1α in combination with lenvatinib effectively inhibited tumor growth and prolonged the survival of tumor-bearing mice by increased the infiltration of T lymphocytes and M1 macrophages within the tumor microenvironment [35]. Here, HIF1A is linked to neoplasm.